Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
Zhou X, Jiang Y, Wang Y, Fan L, Zhu Y, Chen Y, Wang Y, Zhu Y, Wang H, Pan Z, Li Z, Zhu X, Ren R, Ge Z, Lai D, Lai EY, Chen T, Wang K, Liang P, Qin L, Liu C, Qiu C, Simons M, Yu L. Zhou X, et al. Among authors: pan z. Circ Res. 2023 Sep;133(6):508-531. doi: 10.1161/CIRCRESAHA.122.321200. Epub 2023 Aug 17. Circ Res. 2023. PMID: 37589160
Angiorganoid: vitalizing the organoid with blood vessels.
Ma X, Li H, Zhu S, Hong Z, Kong W, Yuan Q, Wu R, Pan Z, Zhang J, Chen Y, Wang X, Wang K. Ma X, et al. Among authors: pan z. Vasc Biol. 2022 Sep 12;4(1):R44-R57. doi: 10.1530/VB-22-0001. Print 2022 Sep 1. Vasc Biol. 2022. PMID: 35994010 Free PMC article. Review.
Autophagy and machine learning: Unanswered questions.
Yang Y, Pan Z, Sun J, Welch J, Klionsky DJ. Yang Y, et al. Among authors: pan z. Biochim Biophys Acta Mol Basis Dis. 2024 May 25:167263. doi: 10.1016/j.bbadis.2024.167263. Online ahead of print. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38801963 Review.
Bringing evidence to the MAFLD-MASLD debate.
Pan Z, Eslam M. Pan Z, et al. Liver Int. 2024 May 27. doi: 10.1111/liv.16000. Online ahead of print. Liver Int. 2024. PMID: 38801209 No abstract available.
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study.
Lu Z, Kong L, Wang B, Wang J, Liu L, Shu Y, Yang L, Sun G, Cao G, Ji Y, Cui T, Liu H, Qiu W, Li N, Li G, Luo H, Hou X, Zhang Y, Yue W, Xue L, Liu Z, Pan Y, Gao S, Wang X, Pan Z, Zhang S, Lin G, Xie Y, Gu K, Ren T, Li W, Li T, Wang S, He W, Fan Y, Liang J, Xia B, Zhao L, Wang S, Shen L. Lu Z, et al. Among authors: pan z. EClinicalMedicine. 2024 May 17;72:102623. doi: 10.1016/j.eclinm.2024.102623. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38800802 Free PMC article.
7,265 results